Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer

Su Jeong Lee, Sin Yeob Lee, Hyo Sung Jeon, Sun Ha Park, Jin Sung Jang, Ga Young Lee, Ji Woong Son, Chang Ho Kim, Won Kee Lee, Sin Kam, Rang Woon Park, Tae In Park, Young Mo Kang, In-San Kim, Tae Hoon Jung, Jae Yong Park

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

Angiogenesis is an essential process in the development, growth, and metastasis of malignant tumors including lung cancer. DNA sequence variations in the vascular endothelial growth factor (VEGF) gene may lead to altered VEGF production and/or activity, thereby causing interindividual differences in the susceptibility to lung cancer via their actions on the pathways of tumor angiogenesis. To test this hypothesis, we investigated the potential association between three VEGF polymorphisms (-460T > C, +405C > G, and 936C > T)/haplotypes and the risk of lung cancer in a Korean population. VEGF genotypes were determined in 432 lung cancer patients and 432 healthy controls that were frequency matched for age and sex. VEGF haplotypes were predicted using Bayesian algorithm in the phase program. Compared with the combined +405 CC and CG genotype, the +405 GG genotype found associated with a significantly decreased risk of small cell carcinoma [SCC; adjusted odds ratio (OR), 0.36; 95% confidence interval (95% CI), 0.17-0.78]. The 936 CT genotype and the combined 936 CT and TT genotype were also associated with a significantly decreased risk of SCC compared with the 936 CC genotype (adjusted OR, 0.47; 95% CI, 0.26-0.85 and adjusted OR, 0.44; 95% CI, 0.24-0.80, respectively). Haplotype CGT was associated with a significantly decreased risk of SCC (adjusted OR, 0.39; 95% CI, 0.18-0.87), whereas haplotype TCC conferred a significantly increased risk of SCC (adjusted OR, 1.63; 95% CI, 1.14-2.33). None of the VEGF polymorphisms studied significantly influenced the susceptibility to lung cancer except SCC. However, haplotypes TCT and TGT were significantly associated with the risk of overall lung cancer, respectively (adjusted OR, 0.38; 95% CI, 0.25-0.60 and adjusted OR, 3.94; 95% CI, 2.00-7.76, respectively). These effects of haplotypes TCT and TGT on lung cancer risk were observed in three major histologic types of lung cancer. These results suggest that the VEGF gene may be contribute to an inherited predisposition to lung cancer.

Original languageEnglish
Pages (from-to)571-575
Number of pages5
JournalCancer Epidemiology Biomarkers and Prevention
Volume14
Issue number3
DOIs
Publication statusPublished - 2005 Mar 1
Externally publishedYes

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Fingerprint Dive into the research topics of 'Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer'. Together they form a unique fingerprint.

  • Cite this

    Lee, S. J., Lee, S. Y., Jeon, H. S., Park, S. H., Jang, J. S., Lee, G. Y., Son, J. W., Kim, C. H., Lee, W. K., Kam, S., Park, R. W., Park, T. I., Kang, Y. M., Kim, I-S., Jung, T. H., & Park, J. Y. (2005). Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiology Biomarkers and Prevention, 14(3), 571-575. https://doi.org/10.1158/1055-9965.EPI-04-0472